肾移植患者低剂量泼尼松龙治疗期间肾上腺功能不全的横断面病例对照研究
该病例对照研究纳入30例长期接受低剂量泼尼松龙(5或7.5 mg/天)的肾移植患者和30例未用泼尼松龙的透析患者,用250-µg Synacthen试验评估肾上腺功能。肾移植组肾上腺功能不全患病率为43%(95%CI 27-61),显著高于对照组3%(95%CI 0.6-17),P=0.0004。结论认为肾移植患者低剂量泼尼松龙治疗期间肾上腺功能不全患病率高,应提高临床警惕。
要点
- 肾移植患者长期低剂量泼尼松龙治疗者肾上腺功能不全患病率高达43%。
- 该患病率显著高于未用泼尼松龙的透析对照组(3%)。
- 应激时可能需要补充糖皮质激素以预防肾上腺危象。
核心结论
- 肾移植后接受低剂量泼尼松龙治疗的患者中肾上腺功能不全患病率高。
- 建议提高对泼尼松龙诱导的肾上腺功能不全的临床警惕,并考虑应激时补充糖皮质激素。
研究设计与样本
- 病例对照研究,纳入30例肾移植后>11个月且接受泼尼松龙(5或7.5 mg/天≥6个月)的患者和30例未用泼尼松龙的透析患者。
- 肾上腺功能通过250-µg Synacthen试验评估,于晨起空腹、停用泼尼松龙48小时后进行。
- 肾上腺功能不全定义为Synacthen注射后30分钟血浆皮质醇<420 nmol/L。
主要发现
- 接受5 mg/天泼尼松龙的患者中9/25例反应不足,接受7.5 mg/天的患者中4/5例反应不足。
关键数值与推荐
- 肾上腺功能正常定义为Synacthen注射后30分钟血浆皮质醇≥420 nmol/L(Roche Elecsys Cortisol II assay)。
临床怎么用
- 对肾移植后长期低剂量泼尼松龙治疗的患者应警惕肾上腺功能不全。
- 在应激情况下应考虑补充糖皮质激素以预防肾上腺危象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maintenance immunosuppressive regimens after renal transplantation (RTx) most often include prednisolone, which may induce secondary adrenal insufficiency, a potentially life-threatening side effect to glucocorticoid (GC) treatment due to the risk of acute adrenal crisis. We investigated the prevalence of prednisolone-induced adrenal insufficiency in RTx patients receiving long-term low-dose prednisolone treatment. METHODS: We performed a case-control study of patients on renal replacement therapy differing in terms of GC exposure. The study included 30 RTx patients transplanted >11 months before enrolment in the study and treated with prednisolone (5 or 7.5 mg prednisolone/day for ≥6 months) and 30 dialysis patients not treated with prednisolone. Patients underwent testing for adrenal insufficiency by a 250-µg Synacthen test performed fasting in the morning after a 48-h prednisolone pause. Normal adrenal function was defined as P-cortisol ≥420 nmol/L 30 min after Synacthen injection. This cut-off is used routinely for the new Roche Elecsys Cortisol II assay and is validated locally based on the Synacthen test responses in 100 healthy individuals. RESULTS: Thirteen RTx patients {43% [95% confidence interval (CI) 27-61]} had an insufficient response to the Synacthen test compared with one patient in the control group [3% (95% CI 0.6-17)] (P = 0.0004). Insufficient responses were seen in 9/25 and 4/5 RTx patients treated with 5 and 7.5 mg prednisolone/day, respectively. CONCLUSIONS: We found a high prevalence of adrenal insufficiency among RTx patients receiving low-dose prednisolone treatment. We therefore advocate for increased clinical alertness towards prednisolone-induced adrenal insufficiency in RTx patients and thus their potential need of rescue GC supplementation during stress.
引用
- Valentin A, Borresen SW, Rix M, et al. Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study. Nephrol Dial Transplant. 2020. PMID: 31539081. doi:10.1093/ndt/gfz180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。